MedPath

Analysis of clinical,histopathological and immunological features of bullous pemphigoid induced by dipeptidyl peptidase -4 inhibitors

Not Applicable
Conditions
Health Condition 1: L120- Bullous pemphigoid
Registration Number
CTRI/2020/08/027157
Lead Sponsor
Indian association of DermatologistsVenereologists and Leprologists
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Recent-onset vesicobullous skin lesions clinically suggestive of bullous pemphigoid

2.Aged 18 years and above

Exclusion Criteria

1)Patients not willing to give consent

2.Patients not willing to follow up for 6 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath